High materiality8/10
AbbVie upgraded to Outperform from Peer Perform at Wolfe Research
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wolfe Research upgrades ABBV to Outperform; target $300; current price $248.66.
- Target $300 vs price $248.66
- Upgrade signals upside
- Bullish setup
Key facts
- 01
Target: $300
- 02
Posted price: $248.66
- 03
Analyst firm: Wolfe Research
- 04
Analyst: Alexandria Hammond
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.